Biomedical Engineering Reference
In-Depth Information
26. Bruinink A (1992) Serum-free monolayer cultures of fetal chick brain and retina:
immunoassays of developmental markers, mathematical data analysis, and establishment of
optimal culture conditions. In: Zbinden G (ed) The Brain in Bits and Pieces. M.T.C,
Zollikon, pp 23-50
27. Bruinink A (2008) In vitro toxicokinetics and dynamics: modelling and interpretation of
toxicity data. In: Gad SC (ed) Preclinical Development Handbook. John Wiley, New York,
pp 509-550
28. Bruinink A, Birchler F (1993) Effects of cisplatin and ORG.2766 in chick embryonic brain
cell cultures. Arch Toxicol 67:325-329
29. Bruinink A, Reiser P (1991). Ontogeny of MAP2 and GFAP antigens in primary cultures of
embryonic chick brain: effect of substratum, oxygen tension, serum and Ara-C. Int J Dev
Neuroscience 9(3):269-279
30. Bruinink A, Sidler C (1997) The neurotoxic effects of ochratoxin-A are reduced by protein
binding but are not affected by
L
-phenylalanine. Toxicol Appl Pharmacol 146:173-179
31. Bruinink A, Zimmermann G, Riesen F (1991) Neurotoxic effects of chloroquine in vitro.
Arch Toxicol 65:480-484
32. Bruinink A, Reiser P, Müller M et al (1992) Neurotoxic effects of bismuth in vitro. Toxicol
in Vitro 6:285-293
33. Bruinink A, Sidler C, Birchler F (1996) Neurotrophic effects of transferrin on embryonic
chick brain and neural retina cell cultures. Int J Dev Neuroscience 14:785-795
34. Bruinink A, Faller P, Sidler C et al (1998) Growth inhibitory factor and zinc affect neural
cell cultures in a tissue specific manner. Chemico-Biol Interact 115:167-174
35. Bruinink A, Siragusano D, Ettel G et al (2001) The stiffness of bone marrow cell-knit
composites is increased during mechanical load. Biomaterials 22:3169-3178
36. Bruinink A, Yu D, Maier P (2002) Short-term assay for the identification of neurotoxic
compounds and their liver derived stable metabolites. Toxicol In Vitro 16(6):717-724
37. Bruinink A, Tobler U, Hälg M et al (2004) Effects of serum and serum heat-inactivation on
human bone derived osteoblast progenitor cells. J Mater Sci: Mater Med 15:497-501
38. Bruinink A, Kaiser J-P, Meyer DC (2005) Effect of biomaterial surface morphologies on
bone marrow cell performance. Adv Eng Mater 7:411-418
39. Bruinink A, Hasler S, Manser P (2009) In vitro effects of SWCNT: role of treatment
duration. Phys Status Solidif B 246:2423-2427
40. Brunner TJ, Wick P, Manser P et al (2006) In vitro cytotoxicity of oxide nanoparticles:
Comparison to asbestos, silica and the effect of solubility. Environ Sci Technol 40:
4374-4381
41. Burguera EF, Bitar M, Bruinink A (2010) Novel in vitro co-culture methodology to
investigate heterotypic cell-cell interactions. Eur Cell Mater 19:166-179
42. Buser D, Broggini N, Wieland M et al (2004) Enhanced bone apposition to a chemically
modified SLA titanium surface. J Dent Res 83:529-533
43. Casals E, Pfaller T, Duschl A et al (2010) Time evolution of the nanoparticle protein corona.
ACS Nano 4:3623-3632
44. Chang T, Wang R, Wu L (2005) Methylglyoxal-induced nitric oxide and peroxynitrite
production in vascular smooth muscle cells. Free Radic Biol Med 38:286-293
45. Chen C, Loe F, Blocki A et al (2011) Applying macromolecular crowding to enhance
extracellular matrix deposition and its remodeling in vitro for tissue engineering and cell-
based therapies. Adv Drug Delivery Rev 63:277-290
46. Davies JT, Lam J, Tomlins PE et al (2010). An in vitro multi-parametric approach to
measuring the effect of implant surface characteristics on cell behaviour. Biomed Mater
5:015002
47. Decaris ML, Lee CI, Yoder MC et al (2009) Influence of the oxygen microenvironment on
the proangiogenic potential of human endothelial colony forming cells. Angiogenesis
12:303-311
48. Deeg JA, Louban I, Aydin D et al (2011) Impact of local versus global ligand density on
cellular adhesion. Nano Lett 11:1469-1476
Search WWH ::
Custom Search